TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer December 16, 1994
TCL Archive Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial. March 1, 2002
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO July 25, 2003
